New data from Eurofins Discovery show that Telomir-1 blocks enzymes that drive disease by turning off critical genes-highlighting its potential...
THE HAGUE, Netherlands, Aug. 7, 2025 /PRNewswire/ -- Over 1.2 million internet-connected healthcare devices and systems with exposure that endanger patient...
Clinician-Designed Supplements Fill a Critical Gap in Midlife Health With Formulas to Address the Most Common Symptoms Women Face PALO...
DALLAS, Aug. 5, 2025 /PRNewswire/ -- The Smart Healthcare Pavilion at Taiwan Expo USA 2025 will take place at the...
Thirteen women-led tech startups have been selected to participate in FourthWave's 16-week 2025 accelerator program that provides founders with one-on-one...
SAN FRANCISCO, Aug. 5, 2025 /PRNewswire/ -- Trust AI, the 'ChatGPT' for dentists, has raised $6 million, the largest seed...
Known for Gut Health Insights, Olive Oil Advocacy, and Myth-Busting Advice, The Dr. Gundry Podcast Has Surpassed One Million Subscribers...
BH-200 (nelivaptan) achieved clinically meaningful reduction in depressive symptoms across the full study population (Difference between BH-200 and placebo in...
Discover how Bioma Probiotics supports weight loss, balances gut health, and helps women reduce bloating, boost energy, and improve digestion...
Company assembles a globally renowned team of clinical and corporate experts to drive commercial expansion, scale its multi-cancer testing platform,...
Company assembles a globally renowned team of clinical and corporate experts to drive commercial expansion, scale its multi-cancer testing platform,...
The digital therapeutics market is anticipated to increase due to the growing global burden of chronic conditions such as diabetes,...
Updated technology allows for better data resolution; helps with quicker diagnosis, results and patient recovery AURORA, Colo., Aug. 4, 2025...
NEURO PMR study evaluates the clinical utility and patient experience of AI-powered portable MRI in an outpatient settingGUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine,...
NEURO PMR study evaluates the clinical utility and patient experience of AI-powered portable MRI in an outpatient settingGUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine,...
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- From Dr. Neil Maresky, CEO, Psyence BioMed (NASDAQ: PBM) Dear Shareholders, Thank...
RADIANT study with vormatrigine in focal onset seizure (FOS) patients over eight weeks demonstrated 56.3% median reduction in seizure frequency...
Dosing with vormatrigine over 8 weeks led to 56.3% median reduction in seizure frequency Approximately 22% of patients reached 100%...
Expanding network’s proprietary EPICC suite of tools for secure, AI-powered replicas of both HCPs and patientsNEW YORK, Aug. 01, 2025...
HOUSTON, TX, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”), the leader...